klow peptide blue blend a lighter blue? : r/PeptidePathways klow blend peptide dosing Blend:

doi: 10.1016/j.exer.2022.109364 225 BiesemeierAYoeruekEEiblOSchraermeyerU

Ismalova, K

As a result of the numerous benefits that have been discovered, 7nAChR is regarded as a potentially beneficial therapeutic target in CNS disorders, including neurodegenerative diseases like Alzheimers disease (AD) and Parkinsons disease, psychiatric disorders like autism and schizophrenia, and cerebrovascular diseases like ischemic stroke, and hemorrhage stroke [29,30,31,32]

Thus, as stated above, the difference in the growing profile between the two depleting agents, DEM and BSO, was not due to changes in the number of dead cells